Our main academic and research areas are metabolic (dysfunction)-associated steatotic liver disease (MASLD) in people with type 2 diabetes. We are also conducting research about hospital management of hyperglycemia, in order to reduce clinical outcomes. Other areas of research carried out by the DEF members are management of diabetes in people undergoing solid organ transplantation, such as liver and kidney transplantation; metabolic bone diseases; calcium dysregulation; thyroid and parathyroid issues.

Our published papers

  1. Kuchay MS, Martínez-Montoro JI. Editorial for “MR Assessed Changes of Renal Sinus Fat in Response to Glucose Regulation in West European and South Asian Patients With Type 2 Diabetes”. J MagnReson Imaging. 2023.PUBMED.
  2. Kuchay MS, Khatana P, Mishra M, et al. Dapagliflozin for inpatient hyperglycemia in cardiac surgery patients with type 2 diabetes: randomised controlled trial (Dapa-Hospital trial). Acta Diabetol. 2023;60(11):1481-1490. PUBMED.
  3. Khanmohammadi S, Ramos-Molina B, Kuchay MS. NOD-like receptors in the pathogenesis of metabolic (dysfunction)-associated fatty liver disease: Therapeutic agents targeting NOD-like receptors. Diabetes Metab Syndr. 2023;17(7):102788.PUBMED.
  4. Kuchay MS, Mathew A, Mishra M, et al. Efficacy and safety of degludec U100 versus glargine U300 for the early postoperative management of patients with type 2 diabetes mellitus undergoing coronary artery bypass graft surgery: A non-inferiority randomized trial. Diabet Med. 2023;40(1):e15002. (PUBMED).
  5. Kuchay MS, Martínez-Montoro JI, Llamoza-Torres CJ, et al. Liver cirrhosis and sarcopenia: a dreadful combination. Hepatobiliary Surg Nutr. 2022;11(5):729-731.PUBMED.
  6. Khanmohammadi S, Kuchay MS. Toll-like receptors and metabolic (dysfunction)-associated fatty liver disease. Pharmacol Res. 2022;185:106507.PUBMED.
  7. Kuchay MS, Misra A. Sodium-glucose cotransporter-2 inhibitors as first-line pharmacological therapy for type 2 diabetes? Diabetes Metab Syndr. 2022;16(8):102580.PUBMED.
  8. Kuchay MS, Martínez-Montoro JI, Kaur P, et al. Non-alcoholic fatty liver disease-related fibrosis and sarcopenia: An altered liver-muscle crosstalk leading to increased mortality risk. Ageing Res Rev. 2022;80:101696. PUBMED.
  9. Kuchay MS, Misra Anoop. Role of diabetologists in the management of nonalcoholic fatty liver disease: primary prevention and screening/management of fibrosis and cirrhosis. Diabetes Metab Syndr. 2022;16(3):102446.PUBMED.
  10. Martínez-Montoro JI, Kuchay MS, Balaguer-Román A, et al. Gut microbiota and related metabolites in the pathogenesis of nonalcoholic steatohepatitis and its resolution after bariatric surgery. Obes Rev. 2021:e13367. PUBMED.
  11. Kuchay MS, Choudhary NS, Sharma D, et al. Diagnostic accuracy and optimal cut-off of controlled attenuation parameter for the detection of hepatic steatosis in Indian population. J Clin Exp Hepatol. 2022;12(3):893-898.PUBMED.
  12. Kuchay MS, Martínez-Montoro JI, Choudhary NS, et al. Non-Alcoholic Fatty Liver Disease in Lean and Non-Obese Individuals: Current and Future Challenges. Biomedicines. 2021; 9(10):1346. PUBMED.
  13. Kuchay MS, Mathew A, Kaur P, et al. Denosumab can be used successfully as a bridge to surgery in patients with severe hypercalcemia due to primary hyperparathyroidism. Arch Endocrinol Metab. 2021;65(5):669-673.PUBMED.
  14. Choudhary NS, Saraf N, Kuchay MS,et al. The association between nonalcoholic fatty liver disease and cardiovascular disease: A window of opportunity. J Clin Cardiol. 2021;10:112-116. PUBMED.
  15. Kuchay MS, Choudhary NS, Mishra SK, et al. Prevalence of clinically relevant liver fibrosis due to nonalcoholic fatty liver disease in Indian Individuals with type 2 diabetes. JGH Open. 2021;5(8):915-922.PUBMED.
  16. Mishra M, Bano T, Mishra SK, et al. Effectiveness of diabetes education including insulin injection technique and dose adjustment through telemedicine in hospitalized patients with COVID-19. Diabetes Metab Syndr. 2021 Jun 12;15(4):102174.PUBMED.
  17. Kuchay MS, Choudhary NS, Gagneja S, et al. Low skeletal muscle mass is associated with liver fibrosis in individuals with type 2 diabetes and nonalcoholic fatty liver disease. J Gastroenterol Hepatol. 2021;36(11):3204-3211.PUBMED.
  18. Kuchay MS, Mishra SK, Mehta Y. Empagliflozin induced euglycemic diabetic ketoacidosis in a patient undergoing coronary artery bypass graft despite discontinuation of the drug 48 hours prior to the surgery. Diabetes Metab Syndr. 2021;15(3):909-911.PUBMED.
  19. Ghosh A, Anjana RM, Shanthi Rani CS, et al. Glycemic parameters in patients with new-onset diabetes during COVID-19 pandemic are more severe than in patients with new-onset diabetes before the pandemic: NOD COVID India Study. Diabetes Metab Syndr. 2021;15(1):215-220. PUBMED.
  20. Boddu SK, Aurangabadkar G, Kuchay MS. New onset diabetes, type 1 diabetes and COVID-19. Diabetes Metab Syndr. 2020;14(6):2211-2217. PUBMED.
  21. Kuchay MS, Choudhary NS, Mishra SK, et al. Nonalcoholic fatty liver disease should be considered for treatment allocation in standard management algorithms for type 2 diabetes. Diabetes Metab Syndr. 2020;14(6):2233-2239.PUBMED.
  22. Boddu SK, Aurangabadkar G,Kuchay MS.New onset diabetes, type 1 diabetes andCOVID-19.Diabetes Metab Syndr. 2020;14(6):2211-2217.PUBMED.
  23. Kuchay MS, Choudhary NS, Mishra SK. Pathophysiological mechanisms underlying MAFLD. Diabetes Metab Syndr. 202024;14(6):1875-1887.PUBMED.
  24. Kuchay MS, Krishan S, Mishra SK, et al. Effect of dulaglutide on liver fat in patients with type 2 diabetes and NAFLD: randomised controlled trial (D-LIFT trial). Diabetologia. 2020;63(11):2434-2445. PUBMED.
  25. Reddy PK, Kuchay MS, Mehta Y, et al. Diabetic ketoacidosis precipitated by COVID-19: A report of two cases and review of literature. Diabetes Metab Syndr. 2020;14(5):1459-1462. PUBMED.
  26. Kuchay MS, Misra A. From non-alcoholic fatty liver disease (NAFLD) to metabolic-associated fatty liver disease (MAFLD): A journey over 40 years. Diabetes Metab Syndr. 2020;14(4):695‐696. PUBMED.
  27. Garg A, Mishra SK, Dubey S, et al. Low-dose ACTH test for evaluation of hypothalamus-pituitary-adrenal axis preoperatively and 3-month follow-up in non-functioning pituitary adenomas. J Endocrinol Invest. 2020;43(12):1769-1777.PUBMED.
  28. Kuchay MS, Farooqui KJ, Mishra SK, et al. Glucose Lowering Efficacy and Pleiotropic Effects of Sodium-Glucose Cotransporter 2 Inhibitors. Adv Exp Med Biol. 2021;1307:213-230.PUBMED.
  29. Bano T, Kuchay MS,Mishra SK, et al. Immediate postoperative complications following coronary artery bypass grafting in patients with type 2 diabetes: a prospective cohort study. Diabetes Metab Syndr. 2019;14:47-51.PUBMED.
  30. Bano T, Mishra SK, Kuchay MS,et al. Continuation of metformin till night before surgery and lactate levels in patients undergoing coronary artery bypass graft surgery. Indian J Endocrinol Metab. 2019;23(4): 416-421.PUBMED.
  31. Mishra SK, Kuchay MS, Sen IB, et al. Successful management of tumor-induced osteomalacia with radiofrequency ablation: A case series. JBMR Plus. 2019;3(7):e10178.PUBMED.
  32. Bansal B, Mithal A, Chopra SR, et al. Judicious use of DXA-BMD in assessing fracture risk by using clinical risk factors in the Indian population. Arch Osteoporos. 2018;13(1):115.PUBMED.
  33. Kuchay MS, Krishan S, Mishra SK, et al. Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial). Diabetes Care. 2018;41(8):1801-1808.PUBMED.
  • Kuchay MS, Bansal B, Mithal A. Pitfalls in interpreting interventional studies for osteoporosis. Clin Cases Miner Bone Metab. 2017;14(3):329-331. PUBMED.
  • Kuchay MS, Kaur P, Mishra SK, et al. The changing profile of hypercalcemia in a tertiary care setting in North India: an 18-month retrospective study. Clin Cases Miner Bone Metab. 2017;14(2):131-135.PUBMED.
  • Kuchay MS, Mishra SK, Bansal B, et al. Glucocorticoid sparing effect of zoledronic acid in sarcoid hypercalcemia. Arch Osteoporos. 2017;12(1):68.PUBMED.
  • Kuchay MS, Farooqui KJ, Mithal A. Acute severe diarrhoea and hyponatremia after zoledronic acid infusion: an acute phase reaction. Clin Cases Miner Bone Metab. 2017;14(1):101-104.PUBMED.
  • Kuchay MS, Farooqui KJ, Jevalikar G, et al. The changing profile of hypercalcemia in hospital populations. Clinic Rev Bone Miner Metab. 2017;15:82-89.PUBMED.
  • Kuchay MS, Mithal A. Levosulpiride and serum prolactin levels. Indian J Endocr Metab. 2017;19:693-695.PUBMED.
  • Kuchay MS, Farooqui KJ, Bano T, et al. Heparin and insulin in the management of hypertriglyceridemia-associated pancreatitis: case series and literature review. Arch Endocrinol Metab. 2017;61:198-201.PUBMED.
  • Kuchay MS, Mishra SK, Farooqui KJ, et al. Hypercalcemia of advanced chronic liver disease: a forgotten clinical entity! Clin Cases Miner Bone Metab. 2016;13(1):15-8.PUBMED.
  • Kuchay MS,Kudyar RP, Gupta A, et al. Gender differences in insulin and C-peptide concentrations at birth using cord blood collection. Arch Endocrinol Metab. 2016;60(3):264-266.PUBMED.
  • Kuchay MS, Jevalikar GS, Mithal A, et al. Efficacy and safety of a single monthly dose of cholecalciferol in healthy school children. J Pediatr Endocrinol Metab. 2016;29(4):413-416.PUBMED.
  • Yedla N, Kuchay MS, Mithal A. Hemoglobin E disease and glycosylated hemoglobin. Indian J Endocr Metab 2015;19:683-685. PUBMED.
  • Kuchay MS,Laway BA, Bashir MI, et al. Effect of Vitamin D supplementation on glycemic parameters and progression of prediabetes to diabetes: A 1-year, open-label randomized study. Indian J Endocr Metab 2015;19:387-92. PUBMED.
  • Bhat M,Laway B,Kuchay M, et al. Recurrent myonecrosis involving adductor muscle group bilaterally: a rare complication of diabetes mellitus. Oman Med J 2014;29(6):445-449. PUBMED.
  • Kuchay MS,Laway BA, Bhat MA, et al. Medical therapy alone can be sufficient for bilateral emphysematous pyelonephritis: report of a new case and review of previous experiences. Int Urol Nephrol 2014;46(1):223-227. PUBMED.
  • Ahmad Bhat M, Ahmad Laway B, et al. Hypokalemic Quadriparesis and Rhabdomyolysis as a rare presentation of Distal Renal Tubular Acidosis. MJIRI 2014;28:35. PUBMED.
  • LawayBA, Shafi KM, Majid S, et al. Incidence of Primary hypothyroidism in patients exposed to therapeutic external beam radiation, where radiation portals include a part or whole of the thyroid gland. Indian J Endocr Metab 2012;16:329-331. PUBMED.
  • Nisar S, Shah PA, Kuchay MS,et al. Association of polycystic ovary syndrome and Graves’ disease: is autoimmunity the link between the two diseases. Indian J Endocr Metab 2012;16:982-986. PUBMED.
  • K K Pandita, Sushil Razdan, R P Kudyar, et al. “Excess gooD can be Dangerous”. A case series of iatrogenic symptomatic hypercalcemia due to hypervitaminosis D.Clin Cases Miner Bone Metab 2012; 9(2):118–120. PUBMED.